Concordia (CXRX) Executes Support Agreement, Obtains Interim Order in Connection with Recapitalization, and Announces Leadership Transition
May 2, 2018 9:01 AM
Concordia International Corp. (NASDAQ: CXRX), an international specialty pharmaceutical company focused on becoming a leader in European specialty, off-patent medicines ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
